Lyniate Launches New Cloud Deployment Option for Market Leading Corepoint Integration Engine Company also Receives ISO 27001 Information Security Certification for all Products

BOC Sciences: A Robust Isotope Labeling Service Vendor

BOC Sciences offers professional stable isotope labeling services to support worldwide partners from preclinical to commercial stages.

Complete Virtual Screening Solutions at BOC Sciences to Unleash Novel Drug Discovery Potential

Today, BOC Sciences released a complete set of virtual screening solutions to help partners maximize the diversity of hits using its ultra-large-scale purchasable compound libraries.

BOC Sciences Unveils Access to Comprehensive Set of PROTAC In Vitro Evaluation Services

BOC Sciences today unveiled access to its comprehensive set of PROTAC in vitro evaluation services for biopharmaceutical clients and partners to expedite their PROTAC development from preclinical studies to clinical trials.

Creative Peptides Unveils Product Portfolio of Standard Fmoc/Boc-PNA Monomers

Creative Peptides supplies standard Fmoc- and Boc-PNA monomers that can be ordered in large quantities with high purity, solubility, and reactivity.

Alfa Chemistry Catalysts Releases Asymmetric Organocatalysts for Chemical Reactions

As a reliable source for versatile catalysts, Alfa Chemistry Catalysts today announces that it has launched a rich of collection of asymmetric organocatalysts, including chiral amines, chiral amino acids, chiral ammonium salts, chiral bicyclic guanidines, chiral diols, chiral imidazolidinones, chiral isothioureas, chiral n-heterocyclic carbenes (NHC), chiral oxazaborolidines, chiral sulfonic acids, cinchona alkaloids, and prolines, proline analogs. All can be used to accelerate different types of chemical reactions for research and production, whereas all are of high purity and of high-popularity among consumers.

MicrobioSeq Releases Nanopore-Based Microbial Epigenomics Solutions to Accelerate Your Research

CD Genomics Supercharges Transcriptomics Research by Digital RNA Sequencing Technology

uMotif – the patient-first data capture and decentralized clinical trials platform – announces $25.5m of new investment from a fund managed by Athyrium Capital Management

uMotif – the patient-first data capture and decentralized clinical trials platform – announces $25.5m of new investment from a fund managed by Athyrium Capital Management LONDON and NEW YORK, May 25, 2022-- uMotif today announced a new investment of $25.5m from a fund managed by Athyrium Capital Management, LP, the New York-based investment firm. The new funding will support continued scale up of uMotif's unique patient-first software platform for clinical research.

CD BioSciences Introduces Comprehensive Solutions for GPCR Expression

CD BioSciences introduces comprehensive solutions for GPCR expression based on various strategies and technique platforms to facilitate customers’ cutting-edge programs.

STEMart Introduces Biocompatibility Evaluation of Breathing Gas Pathways in Medical Devices

STEMart expands its Biocompatibility Testing services and introduces biocompatibility evaluation of breathing gas pathways in medical devices.

Amerigo Scientific Supports Microbiology Research with the Launch of HHD BROTH

Amerigo Scientific now introduces HHD Broth to the life science research community.

Creative Diagnostics Launches Antibody-dependent Enhancement Assay Services

Creative Diagnostics recently introduces comprehensive services for antibody-dependent enhancement (ADE) assay.

New Research Shows More Americans Avoiding Healthcare Due to Uncertainty About Costs

HealthSparq Annual Consumer Survey Reveals Strong Support for Price Transparency Government Mandates

Thermo Fisher Scientific and Qatar Genome Program Partner to Advance Precision Medicine

MMS Holdings Selects THREAD as Partner of Choice to Deliver Decentralized Clinical Trials

MMS Holdings Inc. (MMS) – a data-focused contract research organization (CRO) – announced a collaboration with THREAD® as its partner of choice for its decentralized clinical trial platform (DCT) and DCT-enabled services, solidifying MMS as a full-service DCT provider. The THREAD partnership is one initiative of many at MMS dedicated to accelerating a path toward adopting more patient-focused clinical trials

New study highlights talent needed to grow the biosimilars sector

The RSA Group, a leading life sciences executive search firm, has published the latest of its Talent Equity® Reports: Biosimilars 2022. The new report features interviews with leaders of biosimilars companies who give their unique insights into the challenges and opportunities facing this fast-growing sector and the leadership needed to grow the industry, including the power of creating strong in-house knowledge and evaluating where this talent already exists.

Creative Proteomics Cytokine Unveils Tumor Necrosis Factors (TNF) Detection Service

Creative Proteomics Lipidomics Platform Boosts Short Chain Fatty Acids Research

Pronalyse Unveils Therapeutic Enzyme Characterization Service for Your Drug Development